Results 61 to 70 of about 85,921 (270)

ORAL HYGIENE BURUK PASIEN RAWAT INAP TIDAK BERKAITAN DENGAN PERTUMBUHAN ORAL CANDIDIASIS

open access: yesODONTO: Dental Journal, 2017
Background: Nosocomial infections can develop in the oral cavity due to poor oral hygiene. Oral Candidiasis is one of the most frequent nosocomial infection in oral cavity.
Addina Aimana Sabila   +2 more
doaj   +1 more source

The Fibula Free Flap as Used for Reconstruction in Patients With Oral Cavity Malignancy: A Systematic Review

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
ABSTRACT Objectives The fibula free flap is a widely used means of reconstructing the maxilla and mandible. It is used for a variety of indications, including for reconstruction after resection of a benign or malignant tumor, osteoradionecrosis, or trauma.
Rohan Vuppala   +2 more
wiley   +1 more source

Oral candidiasis: relation to systemic diseases and medications

open access: yesDentistry 3000, 2017
Background: Oral candidiasis is by far the most common oral fungal infection in humans. It is caused by the fungal organism Candida albicans. When the host is debilitated by other diseases and conditions, C.
Xiaozhu Chu
doaj   +1 more source

Vulvovaginal candidiasis-related symptoms and conditions.

open access: yes, 2022
Vulvovaginal candidiasis-related symptoms and conditions.
Brendan R. Jackson (8575074)   +2 more
core   +1 more source

Short‐Term Clinical Outcomes and Complication Timing in Patients With Postoperative Delirium After Major Emergency Abdominal Surgery: A Prospective Cohort Study

open access: yesWorld Journal of Surgery, EarlyView.
Postoperative delirium is linked to increased morbidity, mortality, and prolonged hospitalization; however, its short‐term consequences after major emergency abdominal surgery remain insufficiently studied. This prospective cohort study included 752 patients undergoing major emergency abdominal surgery at Copenhagen University Hospital, Herlev, from ...
Astrid Warmbier Jensen   +5 more
wiley   +1 more source

Salivary iron and Candida colonization in oral lichen planus patients undergoing topical steroid therapy

open access: yesBMC Oral Health
Background The most common adverse event in oral lichen planus (OLP) patients undergoing topical corticosteroid therapy is opportunistic infection with oral Candida.
Auranat Prachayakul   +3 more
doaj   +1 more source

Chronic Mucocutaneous Candidiasis as Primary Immunodeficiency in Children

open access: yesZdorovʹe Rebenka, 2013
Chronic mucocutaneous candidiasis is a genetically heterogeneous group of disorders associated with mutations in genes STAT1, IL17RA, IL17F, AIRE, STAT3, TYK2, IL12RB1, and IL12B.
L.I. Chernyshova   +5 more
doaj   +1 more source

Vaginal azoles versus oral fluconazole in treatment of recurrent vulvovaginal candidiasis [PDF]

open access: yes
Background: Vulvovaginal candidiasis (VVC) is a fungal infection of the vagina and vulva. It is usually caused by Candida albicans, however, occasionally other candida species are responsible. The optimal treatment of VVC has not yet been defined.
فردی آذر, زهرا   +3 more
core  

Systemic Treatment of Psoriasis: Current Evidence on Efficacy and Safety

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Systemic treatments for moderate‐to‐severe plaque psoriasis have been advanced from broad immunosuppressants up to agents more selectively targeting cytokines, cytokine receptors, or intracellular signaling. The current systemic treatments mainly consist of conventional systemic agents, biologics targeting tumor necrosis factor (TNF)‐α ...
Teppei Hagino, Naoko Kanda
wiley   +1 more source

Effectiveness and Safety of Vunakizumab Over 12 Weeks in Chinese Patients With Plaque Psoriasis: A Prospective, Real‐World Cohort Study

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Vunakizumab is a humanized anti‐IL‐17A monoclonal antibody approved in China for moderate‐to‐severe plaque psoriasis. Real‐world data on its effectiveness and predictors of response remain scarce. This prospective, single‐center, observational study enrolled 34 adults receiving vunakizumab (240 mg subcutaneously at weeks 0, 2, and 4, then ...
Tong Wu   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy